By 2050, 1.3 billion diabetics worldwide been forecast
In 2023, The Lancet published a result of the Global Burden of Disease Study (GBD Study 2021) online, estimating the global burden of diabetes for 1990-2021 and making projections for 2050. The analysis shows that in 2021, there were 529 million people suffering from diabetes worldwide, with an age-standardized prevalence of 6.1%. It is forecast that by 2050, 1.31 billion people will suffer from diabetes worldwide.
Among the symptoms of diabetes, there are typical manifestations of excessive drinking and eating, and diabetes is a chronic disease, like hypertension and heart disease, there may not have obvious discomfort symptoms in the early stage, so it is easy to be ignored. Mostly when they have gotten sick for many years, and the situation becomes more serious and obvious symptoms of discomfort appear, but then the patient already has a lot of complications, and patient’s condition mostly can not be reversed by drugs.
People at high risk of diabetes are who have a family history of diabetes, who are overweight, have an unhealthy diet, lack of physical exercises, get old, who have high blood pressure, impaired glucose tolerance (IGT), have a history of gestational diabetes, and who are at high risk of diabetes and have malnutrition during pregnancy. Usually a physical examination is required to prevent the occurrence of complications through early control of stable blood sugar levels
Wizbiotech has developed its own glycosylated hemoglobin (HbA1c) assay kit. Compared with home blood glucose meters, which can only measure the immediate blood glucose level and cannot be used to evaluate the degree of disease control, the HbA1c assay kit can reflect the average blood glucose level of 8-12 weeks, which is a good indicator of long-term diabetes control. It was listed as the gold standard for diabetic blood sugar control in 2002. The operation is simple, and the test results can be obtained in 15 minutes, which is suitable for use in endocrinology departments, clinical departments, basic health centers, diabetes third-party management institutions, etc.
If you need to know more about our products, please contact us (click here to jump to see the company's contact information).
